Trial Profile
A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18 - 65 Years
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2020
Price :
$35
*
At a glance
- Drugs Diphencyprone (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Phio Pharmaceuticals; RXi Pharmaceuticals
- 06 Feb 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Feb 2018).
- 14 Aug 2018 According to an RXi Pharmaceuticals media release,Status changed from active, no longer recruiting to completed.
- 18 May 2018 Results presented in the RXi Pharmaceuticals media release.